AGI-134

CAT: 0804-HY-156996Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-156996Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
AGI-134 is a fully synthetic alpha-Gal glycolipid. AGI-134 invokes CD8+ T cell-mediated immunity. AGI-134 induces tumor cell destruction and phagocytosis[1].
CAS Number
[1821461-84-0]
UNSPSC
12352005
Target
Biochemical Assay Reagents
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/agi-134.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H](O[C@H]([C@@H]([C@H]1O)NC(C)=O)OCCCNC(CCCCC(NCCOP(OC[C@@H](COC(CCCCCCC/C=C\CCCCCCCC)=O)OC(CCCCCCC/C=C\CCCCCCCC)=O)(O)=O)=O)=O)[C@H]1O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O[C@H]3O[C@@H]([C@@H]([C@@H]([C@H]3O)O)O)CO)O
Molecular Formula
C70H126N3O26P
Molecular Weight
1456.73
References & Citations
[1]Irit Carmi LEVY, et al. Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors. WO2019229745A1. 2019.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2

Related Products

CatalogName
HY-145777-01AGI-43192
HY-112130-01AGI-24512
HY-145778-01AGI-41998
HY-121736-01AGI-12026
HY-112129-01AGI-25696
HY-18082-01AGI-5198
HY-15734-01AGI-6780
HY-120181-01AGI-14100
HY-168623EGFR-IN-134
HY-141810MT-134

Alternative Products

CatalogName
MF-0062195-01AGI-134
MBS3601841-01AGI-6780
MBS3603448-01AGI-1067
MBS3844699-01AGI-25696
GW1673-25mgAGI-5198
MBS5812856AGI-16903
BA5817-10AGI-43192
BA4944-5AGI-24512
BA5815-10AGI-41998
MBS5750103AGI 1067

Popular Products